Tune Therapeutics is developing epi-therapeutic medicines using its TEMPO platform to control the epigenome and adjust gene expression levels without permanently rewriting DNA. This approach can reverse pathways of cancer, genetic disease, and aging, and has the potential to treat thousands of complex and chronic diseases.